Cipla Health Champions WHO-Approved Rehydration with #AsliORS
Cipla Health Limited's ProlyteORS brand aligns with a new FSSAI directive, which restricts the use of 'ORS' in products not following WHO formulations. Cipla, committed to consumer trust and efficacy, supports transparency and safe rehydration solutions, reinforcing its brand as a reliable choice for effective rehydration.
- Country:
- India
Cipla Health Limited's flagship brand, ProlyteORS, applauded the recent FSSAI directive aimed at regulating the use of 'ORS' in product names unless they conform to WHO-approved Oral Rehydration Solution formulations. This move highlights a crucial alignment between regulatory intent and Cipla's commitment to brand integrity and consumer transparency.
Shivam Puri, MD & CEO at Cipla Health, emphasized the directive's importance for consumer trust and public health. ProlyteORS, a market leader in rehydration solutions, has consistently adhered to high standards of formulation integrity, embodying Cipla's pledge to transparency, quality, and efficacy.
Cipla Health, established in 2015, stands as a pioneer in wellness with a diverse portfolio across various health categories. The company continues to lead in various segments, reinforcing its reputation as a reliable provider of safe and effective wellness solutions.
Google News